184 related articles for article (PubMed ID: 31728901)
1. Foam Cell-Derived CXCL14 Muti-Functionally Promotes Atherogenesis and Is a Potent Therapeutic Target in Atherosclerosis.
Tong W; Duan Y; Yang R; Wang Y; Peng C; Huo Z; Wang G
J Cardiovasc Transl Res; 2020 Apr; 13(2):215-224. PubMed ID: 31728901
[TBL] [Abstract][Full Text] [Related]
2. IgE Contributes to Atherosclerosis and Obesity by Affecting Macrophage Polarization, Macrophage Protein Network, and Foam Cell Formation.
Zhang X; Li J; Luo S; Wang M; Huang Q; Deng Z; de Febbo C; Daoui A; Liew PX; Sukhova GK; Metso J; Jauhiainen M; Shi GP; Guo J
Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):597-610. PubMed ID: 31996021
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of vasostatin-1 against atherogenesis.
Sato Y; Watanabe R; Uchiyama N; Ozawa N; Takahashi Y; Shirai R; Sato K; Mori Y; Matsuyama T; Ishibashi-Ueda H; Hirano T; Watanabe T
Clin Sci (Lond); 2018 Dec; 132(23):2493-2507. PubMed ID: 30401690
[TBL] [Abstract][Full Text] [Related]
4. Epac1 (Exchange Protein Directly Activated by cAMP 1) Upregulates LOX-1 (Oxidized Low-Density Lipoprotein Receptor 1) to Promote Foam Cell Formation and Atherosclerosis Development.
Robichaux WG; Mei FC; Yang W; Wang H; Sun H; Zhou Z; Milewicz DM; Teng BB; Cheng X
Arterioscler Thromb Vasc Biol; 2020 Dec; 40(12):e322-e335. PubMed ID: 33054390
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Orai1 Store-Operated Calcium Channel Prevents Foam Cell Formation and Atherosclerosis.
Liang SJ; Zeng DY; Mai XY; Shang JY; Wu QQ; Yuan JN; Yu BX; Zhou P; Zhang FR; Liu YY; Lv XF; Liu J; Ou JS; Qian JS; Zhou JG
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):618-28. PubMed ID: 26916730
[TBL] [Abstract][Full Text] [Related]
6. Alteration of volume-regulated chloride channel during macrophage-derived foam cell formation in atherosclerosis.
Hong L; Xie ZZ; Du YH; Tang YB; Tao J; Lv XF; Zhou JG; Guan YY
Atherosclerosis; 2011 May; 216(1):59-66. PubMed ID: 21338988
[TBL] [Abstract][Full Text] [Related]
7. Elevated microRNA-155 promotes foam cell formation by targeting HBP1 in atherogenesis.
Tian FJ; An LN; Wang GK; Zhu JQ; Li Q; Zhang YY; Zeng A; Zou J; Zhu RF; Han XS; Shen N; Yang HT; Zhao XX; Huang S; Qin YW; Jing Q
Cardiovasc Res; 2014 Jul; 103(1):100-10. PubMed ID: 24675724
[TBL] [Abstract][Full Text] [Related]
8. Proteoglycan 4 regulates macrophage function without altering atherosclerotic lesion formation in a murine bone marrow-specific deletion model.
Nahon JE; Hoekstra M; Havik SR; Van Santbrink PJ; Dallinga-Thie GM; Kuivenhoven JA; Geerling JJ; Van Eck M
Atherosclerosis; 2018 Jul; 274():120-127. PubMed ID: 29772480
[TBL] [Abstract][Full Text] [Related]
9. Chondroitin Sulfate
Adhikara IM; Yagi K; Mayasari DS; Suzuki Y; Ikeda K; Ryanto GRT; Sasaki N; Rikitake Y; Nadanaka S; Kitagawa H; Miyata O; Igarashi M; Hirata KI; Emoto N
Arterioscler Thromb Vasc Biol; 2021 Mar; 41(3):1076-1091. PubMed ID: 33504177
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor 21 regulates foam cells formation and inflammatory response in Ox-LDL-induced THP-1 macrophages.
Wang N; Li JY; Li S; Guo XC; Wu T; Wang WF; Li DS
Biomed Pharmacother; 2018 Dec; 108():1825-1834. PubMed ID: 30372888
[TBL] [Abstract][Full Text] [Related]
11. NG2 Proteoglycan Ablation Reduces Foam Cell Formation and Atherogenesis via Decreased Low-Density Lipoprotein Retention by Synthetic Smooth Muscle Cells.
She ZG; Chang Y; Pang HB; Han W; Chen HZ; Smith JW; Stallcup WB
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):49-59. PubMed ID: 26543095
[TBL] [Abstract][Full Text] [Related]
12. ALDH2 deficiency inhibits Ox-LDL induced foam cell formation via suppressing CD36 expression.
Wei S; Zhang L; Bailu Wang ; Zhao Y; Dong Q; Pan C; Li C; He D; Yuan Q; Xu F; Chen Y
Biochem Biophys Res Commun; 2019 Apr; 512(1):41-48. PubMed ID: 30853183
[TBL] [Abstract][Full Text] [Related]
13. Intermedin inhibits macrophage foam-cell formation via tristetraprolin-mediated decay of CD36 mRNA.
Dai XY; Cai Y; Sun W; Ding Y; Wang W; Kong W; Tang C; Zhu Y; Xu MJ; Wang X
Cardiovasc Res; 2014 Feb; 101(2):297-305. PubMed ID: 24253523
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA CDKN2B-AS1 contributes to atherosclerotic plaque formation by forming RNA-DNA triplex in the CDKN2B promoter.
Ou M; Li X; Zhao S; Cui S; Tu J
EBioMedicine; 2020 May; 55():102694. PubMed ID: 32335370
[TBL] [Abstract][Full Text] [Related]
15. Trimethylamine N-oxide promotes atherosclerosis via CD36-dependent MAPK/JNK pathway.
Geng J; Yang C; Wang B; Zhang X; Hu T; Gu Y; Li J
Biomed Pharmacother; 2018 Jan; 97():941-947. PubMed ID: 29136772
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-36γ aggravates macrophage foam cell formation and atherosclerosis progression in ApoE knockout mice.
Zhang M; Liu J; Gao R; Hu Y; Lu L; Liu C; Ai L; Pan J; Tian L; Fan J
Cytokine; 2021 Oct; 146():155630. PubMed ID: 34246054
[TBL] [Abstract][Full Text] [Related]
17. Macrophage iron retention aggravates atherosclerosis: Evidence for the role of autocrine formation of hepcidin in plaque macrophages.
Xiao L; Luo G; Guo X; Jiang C; Zeng H; Zhou F; Li Y; Yu J; Yao P
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Feb; 1865(2):158531. PubMed ID: 31666189
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor I reduces lipid oxidation and foam cell formation via downregulation of 12/15-lipoxygenase.
Sukhanov S; Snarski P; Vaughn C; Lobelle-Rich P; Kim C; Higashi Y; Shai SY; Delafontaine P
Atherosclerosis; 2015 Feb; 238(2):313-20. PubMed ID: 25549319
[TBL] [Abstract][Full Text] [Related]
19. [Toll-like receptor 4 promotes macrophage foam cell formation induced by oxidized low-density/β₂-glycoprotein I/β₂-glycoprotein I antibodies complex].
Zhang X; Zhou H; Xu Y; Liu J; Xie H; Kong X; Xie Y; Yan J
Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Mar; 42(3):208-13. PubMed ID: 24831477
[TBL] [Abstract][Full Text] [Related]
20. Leonurine Prevents Atherosclerosis Via Promoting the Expression of ABCA1 and ABCG1 in a Pparγ/Lxrα Signaling Pathway-Dependent Manner.
Jiang T; Ren K; Chen Q; Li H; Yao R; Hu H; Lv YC; Zhao GJ
Cell Physiol Biochem; 2017; 43(4):1703-1717. PubMed ID: 29045950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
